Physician profile
Amanda Santos
NPI 1538755590
$1,832.57
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,833.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $320.02 | 2021 | |
| Abbvie INC. | $309.19 | 2021 | |
| Amarin Pharma, INC. | $235.79 | 2021 | |
| Pfizer INC. | $138.19 | 2021 | |
| Amgen INC. | $125.75 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.26 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $91.82 | 2021 | |
| Glaxosmithkline, LLC. | $80.54 | 2021 | |
| Merck Sharp & Dohme LLC | $70.48 | 2021 | |
| Daiichi Sankyo INC. | $69.84 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $52.29 | 2021 | |
| Sanofi-Aventis U.S. LLC | $42.35 | 2021 | |
| Genentech USA, INC. | $33.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.24 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $30.54 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $24.97 | 2021 | |
| Biogen, INC. | $20.41 | 2021 | |
| Dexcom, INC. | $13.72 | 2021 | |
| Currax Pharmaceuticals LLC | $13.71 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.39 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.